Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. FHI
FHI logo

FHI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Federated Hermes Inc (FHI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
55.680
1 Day change
-0.48%
52 Week Range
59.050
Analysis Updated At
2026/05/08
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Federated Hermes is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is near a technical pivot but momentum is weak, analyst sentiment is mixed-to-negative, and insiders are selling. While the company has strong AUM momentum and recent business wins, the current setup does not offer a clean enough entry for an impatient buyer, so I would not call it a buy today.

Technical Analysis

FHI is trading pre-market at 54.34, below the pivot level of 55.48 and close to support at 53.17. MACD histogram is negative at -0.271 and still widening lower, which points to ongoing downside momentum. RSI_6 at 38.07 is neutral-to-weak, not oversold enough to signal a strong rebound. Moving averages are converging, suggesting a choppy consolidation rather than a clear uptrend. Short-term pattern data also looks modest, with only limited upside probability over the next week and month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish from positioning, with a very low put-call open interest ratio of 0.19. However, option volume is zero today, so there is no active trading confirmation. IV is relatively subdued, with 30d IV around 32.34 and IV rank of 9.26, indicating the market is not pricing in a major event move. Overall, options positioning leans positive but is not strong enough to override weak price momentum.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
8

Positive Catalysts

  • ["Record Q1 2026 assets under management of $907 billion.", "Record gross equity sales of $9.1 billion in Q1 2026.", "Hedge funds are aggressively buying, with buying up 2165.12% over the last quarter.", "Recent leadership update in global equities could support continuity in the investment platform."]

Neutral/Negative Catalysts

  • ["JPMorgan and TD Cowen both lowered price targets on 2026-05-04.", "JPMorgan maintained Underweight and flagged weaker fund performance and less favorable money market seasonality.", "TD Cowen kept Hold and cited investor concern about slowing money market growth and market share erosion.", "Insiders are selling, with selling up 277.88% over the last month.", "Technical momentum is weak, with negative MACD and price below pivot resistance.", "Recent pattern-based trend data suggests only modest near-term upside."]

Financial Performance

Latest quarter: Q1 2026. Revenue declined sharply to -14.68 million, down 103.56% YoY, which is the main weak spot in the snapshot. Net income was 96.38 million, roughly flat to slightly down YoY at -0.25%. EPS improved to 1.33, up 6.40% YoY, showing earnings resilience despite the revenue decline. The standout fundamental positive is continued AUM expansion, which supports the longer-term franchise.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has turned more cautious recently. On 2026-05-04, JPMorgan cut its target to $53 from $56 and kept Underweight, while TD Cowen cut its target to $54 from $58 and kept Hold. Earlier in April and March, RBC and Evercore were more constructive, with RBC raising to $56 and Evercore raising to $60, but the latest revisions show a downward shift in expectations. Wall Street today is mixed overall, but the near-term tilt is bearish to neutral rather than clearly bullish.

Wall Street analysts forecast FHI stock price to fall
4 Analyst Rating
Wall Street analysts forecast FHI stock price to fall
1 Buy
3 Hold
0 Sell
Hold
Current: 55.950
sliders
Low
51
Averages
53.75
High
56
Current: 55.950
sliders
Low
51
Averages
53.75
High
56
JPMorgan
Kenneth Worthington
Underweight
downgrade
$56 -> $53
AI Analysis
2026-05-04
Reason
JPMorgan
Kenneth Worthington
Price Target
$56 -> $53
AI Analysis
2026-05-04
downgrade
Underweight
Reason
JPMorgan analyst Kenneth Worthington lowered the firm's price target on Federated Hermes to $53 from $56 and keeps an Underweight rating on the shares.
TD Cowen
Bill Katz
Hold
downgrade
$58 -> $54
2026-05-04
Reason
TD Cowen
Bill Katz
Price Target
$58 -> $54
2026-05-04
downgrade
Hold
Reason
TD Cowen analyst Bill Katz lowered the firm's price target on Federated Hermes to $54 from $58 and keeps a Hold rating on the shares. The firm said dDespite 1Q beat, shares stock declined roughly 7% which they attribute to investors overreacting to commentary on slowing year-over-year industry money market growth along with some market share erosion.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for FHI
Unlock Now

People Also Watch